INTRODUCTION
The retinoid N- (4-hydroxyphenyl) retinamide (HPR) inhibits growth and induces apoptosis in many human cell lines, including many all-trans retinoic acid-resistant ones [1] . HPR's cytotoxicity is mediated through retinoic acid receptor-dependent andindependent mechanisms [2] , may involve p53 independent pathways [3;4] , is associated with the generation of reactive oxygen species (ROS) [5] , is coupled with c-Jun Nterminal kinase (JNK) activation [6] , and may require elevated levels of ceramide [7] .
We previously reported that at clinically achievable concentrations, HPR is a potent and selective inducer of G 1 cell cycle arrest and apoptosis in HTLV-I-positive and HTLV-I-negative malignant T-cells with no effect on normal T-lymphocytes [8] . In HTLV-I-negative cells only, HPR-induced apoptosis was associated with ceramide accumulation, sharp decrease in mitochondrial membrane potential, and activation of caspases 8, 9 and 3, and could be partially reverted by the caspase inhibitor z-VAD. In contrast, HTLV-I-positive cells had a slower apoptotic response and required higher HPR concentrations suggesting that Tax, or other HTLV-I products, protected infected cells from ceramide accumulation and caspase-mediated apoptosis [8] .
Ceramide, a sphingolipid second messenger molecule, has been proposed as a coordinator of eukaryotic stress responses [9] . Many inducers of stress responses result in ceramide accumulation, usually as a result of sphingomyelin breakdown or by de novo synthesis, and sometimes as a result of inhibition of ceramide clearance through [22] [23] [24] ; while elevation of endogenous ceramide levels lowers the threshold for apoptosis induction by these agents [25;26] . Cell permeable ceramide analogs can also produce the growth suppressive effects of these inducers [27] .
Several studies described elevations in ceramide levels following HPR treatment and its role in apoptosis [28] . HL-60 leukemic cells were first shown to exhibit a transient rise in ceramide levels upon HPR treatment and the addition of fumonis in B 1 , an inhibitor of ceramide de novo synthesis, inhibited HPR-induced apoptosis, while the addition of caspase inhibitors had no effect on ceramide levels suggesting that ceramide is upstream of caspase activation [29] . Neuroblastoma cells showed a sustained elevation in ceramide levels upon HPR treatment at concentrations that induced both necrosis and apoptosis and again, fumonisin B1 inhibited apoptosis [4] . This HPR-induced ceramide accumulation in neuroblastoma cell lines was due to the coordinate activation of serine palmitoyltransferase and ceramide synthase of the de novo synthesis pathway [30] . As a consequence, combinations of HPR and some modulators of ceramide metabolism may provide a novel chemotherapeutic approach [31] . In other studies, cytotoxic concentrations of HPR were shown to increase ceramide levels in acute lymphoblastic leukemia cell lines and inhibitors of the ceramide de novo pathway abrogated ceramide accumulation [32] . Furthermore, PC-3 prostate cancer cells, which are relatively resistant to HPR, were rendered much more sensitive by blocking the metabolism of ceramide to glucosylceramide using tamoxifen [33] . All these studies firmly establish ceramide as an important player in apoptosis induction by HPR. 
Growth Assays

Ceramide Measurement
Lipids were collected according to the method of Bligh and Dyer [35] . Ceramide
was measured with a modified diacylglycerol kinase assay using external ceramide standards as described [36] . Briefly, 80% of the lipid sample was dried under N 2 . The by mass spectrometry. Data were normalized to total protein levels.
Microsome Preparation
Microsomes were prepared by sonication of cell pellets from CEM and HuT-102 cells in 25 mM Tris, pH 7.4, 5 mM EDTA, 1 mM PMSF and 1x complete protease inhibitor (Roche, Mannheim, Germany) containing buffer. The preparation was centrifuged at 1000xg, and the resulting supernatant was then ultra centrifuged at 100,000xg. The pellet was resuspended by homogenization in HEPES buffer pH 7.4 (20 mM HEPES, 2 mM KCl, 2 mM MgCl 2 ). Protein concentration was determined using the DC protein assay (Bio-Rad Laboratories, Hercules, CA).
In vitro Ceramide Synthase Activity Assay
Ceramide synthase activity was determined using microsome fractions isolated from HPR-treated and control cells. 50 µg of microsomal proteins were incubated in 25 mM potassium phosphate, pH 7.4 containing 50 µM palmitoyl CoA and 15 µM D-erythro17Sphingosine (a kind gift from Dr. Alicia Bielawska, Medical University of South Carolina, Charleston, South Carolina, USA) delivered using bovine serum albumin as vehicle. The incubation was performed for 15 minutes at 37 0 C and was stopped by the addition of the extraction solvent. Extracted lipids were used to measure the levels of 17C16-Ceramide by mass spectrometry. acetate/isopropanol/water (60/30/10, v/v), evaporated to dryness and reconstituted in 100
Mass Spectrometric Analysis of Lipids
µl of methanol. The analysis was performed using electrospray ionization MS/MS analysis on a Thermo Finnigan TSQ 7000 triple quadruple mass spectrometer, operating in multiple reactions monitoring positive ionization mode, as previously described [37] .
Statistical Analysis
Three statistical tests were performed to validate the significance of the observed results:
The Dunnett test, the two-way analysis of variance test, and the two-sample t-test.
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RESULTS
HPR induces distinct ceramide responses in HTLV-I-negative and positive malignant T cells
The effects of HPR treatment on ceramide levels were examined in HTLV-Inegative cells. A time-dependent increase in ceramide was observed in CEM ( t-test) (Fig. 1D ), after significant cell death had occurred [8] . Also, lower HPR doses had no effect (p< 0.01; Dunnett test) (Fig. 1E ). 
HPR induces de novo synthesis of ceramide in HTLV-I-negative, but not in HTLV-Ipositive, malignant cells
Inhibition of glucosylceramide synthase increases sensitivity to HPR-induced cell death in HTLV-I-positive cells
It was then decided to determine whether increasing endogenous levels of ceramide in HTLV-1-positive cells renders them more sensitive to HPR. We investigated the effect of PDMP, an inhibitor of glucosylceramide synthase (GCS) [38] and thus, an days showed no effect on cell viability in all cell lines, underscoring the specificity of ceramide action (Table 1) .
Recently, C6-ceramides were shown to induce the generation of endogenous long chain ceramides [39] . independent of the CREB/ATF pathway, which is also dysregulated by Tax [43] .
Interestingly, p53 was found to regulate the generation of ceramide in response to chemotherapeutic agents or γ-irradiation [44] . Therefore, one future aim will be to examine whether NF-B and p53 mediate the inhibitory effects of Tax 
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